Global HumanMicrobiome Market, by Product Type (Foods, Diagnostic Devices/Kits, Drugs,and Others), by Application (Therapeutics and Diagnostics), by DiseaseIndication (Gastrointestinal Disorders, Metabolic Disorders, Women Health,Cancer, and Others), by Distribution Channel (Hospital Pharmacy, RetailPharmacy, and Online Pharmacy), and by Region (North America, Latin America,Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 46,913.4million in 2017, and is projected to exhibit a CAGR of 17.5% over the forecastperiod (2018 – 2026).
High number of collaborationactivities between key players and academia Increasing number of collaborationactivities between various players in the market and between different playersand research institutes is expected to aid in the expansion and development ofnovel medicines for variety of diseases. For instance, in 2017, AOBiome securedUS$ 30 million investment for advancing clinical research on systemic andtopical inflammatory disorders using novel bacterial platform from iCarbonX. Itis evident that such efforts are accelerating the research and development ofmicrobiome platform.
* The sample copy includes: Report Summary, Table ofContents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/182
Similarly, in 2017, StanfordUniversity School of Medicine and Vedanta Biosciences Inc. entered in researchcollaboration to focus on food allergies in children and on patients with C.difficile infection or graft-versus-host disease
Browse 36 Market Data Tables and35 Figures spread through 220 Pages and in-depth TOC on ‘Human MicrobiomeMarket’- Global Forecast to 2026, by Product Type (Foods, DiagnosticDevices/Kits, Drugs, and Others), by Application (Therapeutics, andDiagnostics), by Disease Indication (Gastrointestinal Disorders, MetabolicDisorders, Women Health, Cancer, and Others), by Distribution Channel (HospitalPharmacy, Retail Pharmacy, and Online Pharmacy), and by Region (North America,Latin America, Europe, Asia Pacific, Middle East, and Africa).
Growing incidence of diseaseconditions in which human microbiome product is used. According to data givenby Centre for Disease Control and Prevention in October 2017, Clostridiumdifficile infection (CDI) is one of the most common healthcare-associatedinfections in the China and Hong Kong, affecting around 36.1 cases/100,000person in 2014, an annual increase of 26%. According to study published inClinical Infectious Disease journal in 2015, about 25% to 33% ofantibiotic-associated diarrhea and 90% of pseudomembranous enteritis are causedby CDI.
Browse ResearchReport: https://www.coherentmarketinsights.com/market-insight/human-microbiome-market-182
Key Takeaways of the HumanMicrobiome Market:
The global human microbiomemarket is expected to exhibit a CAGR of 17.5% over the forecast period, owingto increasing prevalence of cardiopulmonary conditions, cancer, and renaldiseases.
Among product type, the foodssegment held a dominant position in the human microbiome market in 2017, owingto high adoption of probiotics-based food and beverages for maintaining balanceof microbiomes
Among disease type, cancerdisease held a dominant position in the human microbiome market in 2017. InSeptember 2018, World Health Organization (WHO), stated that cancer is thesecond largest cause of deaths globally.
Among application, diagnosticssegment held a dominant position in the human microbiome market in 2017, asemergence of diagnosis in early stage of cancer and other diseases is proven tobe beneficial in disease management.
Key players operating in theglobal human microbiome market include Enterome Bioscience, Yakult Honsha Co.,Ltd., DuPont, Metabiomics Corporation, ViThera Pharmaceuticals, Second Genome Inc.,AOBiome LLC, Seres Therapeutics, uBiome, Inc., Rebiotix, Inc., SyntheticBiologics, Inc., MicroBiome Therapeutics LLC, Vedanta BioSciences, Osel, Inc.,and Merck & Co., Inc.
Buy-Now this researchreport: https://www.coherentmarketinsights.com/insight/buy-now/182
AboutCoherent Market Insights:
Coherent MarketInsights is a prominent market research and consulting firm offeringaction-ready syndicated research reports, custom market analysis, consultingservices, and competitive analysis through various recommendations related toemerging market trends, technologies, and potential absolute dollaropportunity.
ContactUs:
mailto:sales@coherentmarketinsights.com
U.S.Office:
Name: Mr. Shah
CoherentMarket Insights 1001 4th Ave,
# 3200Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
